Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
December 3, 2007

AEterna Zentaris Sells Echelon to Frontier Scientific for $3.2M

  • Frontier Scientific bought Echelon Biosciences from AEterna Zentaris in a transaction valued at $3.2 million. This includes $2.6 million payable upfront and a $0.6 million in contingent consideration.

    Frontier Scientific and Echelon focus on a common life science research customer base, which includes pharmaceutical companies and research universities around the world. The firms will maintain their current facilities in Logan and Salt Lake City, both in Utah.

    Frontier Scientific supplies specialized biochemical synthetic organic chemistry. Echelon develops and markets reagents and assays to look inside the human cell at lipids-related signaling mistakes.

    “Frontier Scientific and Echelon Biosciences both have outstanding personnel and complementary markets, technologies, facilities, and operations,” comments Jerry Bommer, president of Frontier Scientific. “The acquisition will lead to new technology development and growth opportunities.”

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.